Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)

NCT00086515 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

701

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type II

Interventions

DRUG: Sitagliptin (MK0431)
DRUG: Placebo/Glipizide 5 mg
DRUG: Metformin
DRUG: Pioglitazone

Sponsor

Merck Sharp & Dohme LLC